james rowan
The biopharmaceuticals market is witnessing strong growth, driven by rising demand for biologics, monoclonal antibodies, and advanced therapies for chronic and rare diseases. With increasing investments in biotechnology R&D and breakthroughs in cell and gene therapies, the sector is shaping the future of precision medicine. North America and Europe remain key markets, while Asia-Pacific is emerging rapidly with expanding healthcare infrastructure.